Literature DB >> 21145377

The role of Cdk5 in cognition and neuropsychiatric and neurological pathology.

David G S Barnett1, James A Bibb.   

Abstract

Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase that is ubiquitous in the nervous system and interacts with a myriad of substrates. Its modulation of synaptic plasticity and associated mechanisms of learning and memory as well as neurodegeneration and cognitive disease highlights its importance in the human brain. Cdk5 is active throughout the neuron via its kinase activity, protein-protein interactions, and nuclear associations. It regulates functions thought vital to memory and plasticity, including synaptic vesicle recycling, dendritic spine formation, neurotransmitter receptor density, and neuronal excitability. Although conditional knockout of Cdk5 improves learning and plasticity, the associated deleterious effects of increased excitability cast doubts on the therapeutic efficacy of systemic inhibitors. However, through further work on the regulation of Cdk5 and its effectors, this important molecule promises to aid in elucidating key pathways involved in learning and memory and uncover innovative therapeutic targets to treat neurodegenerative and neuropsychiatric diseases.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145377      PMCID: PMC3073157          DOI: 10.1016/j.brainresbull.2010.11.016

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  54 in total

Review 1.  Modes of vesicle retrieval at ribbon synapses, calyx-type synapses, and small central synapses.

Authors:  Ling-Gang Wu; Timothy A Ryan; Leon Lagnado
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

2.  Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing.

Authors:  Yi Wen; W Haung Yu; Bryan Maloney; Jason Bailey; Junrong Ma; Isabelle Marié; Thomas Maurin; Lili Wang; Helen Figueroa; Mathieu Herman; Pavan Krishnamurthy; Li Liu; Emmanuel Planel; Lit-Fui Lau; Debomoy K Lahiri; Karen Duff
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

3.  Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2.

Authors:  Brad E Pfeiffer; Tong Zang; Julia R Wilkerson; Makoto Taniguchi; Marina A Maksimova; Laura N Smith; Christopher W Cowan; Kimberly M Huber
Journal:  Neuron       Date:  2010-04-29       Impact factor: 17.173

4.  Activity-dependent bulk endocytosis and clathrin-dependent endocytosis replenish specific synaptic vesicle pools in central nerve terminals.

Authors:  Giselle Cheung; Orla J Jupp; Michael A Cousin
Journal:  J Neurosci       Date:  2010-06-16       Impact factor: 6.167

5.  No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro.

Authors:  Dylan W Peterson; D Michael Ando; Daryl A Taketa; Hongjun Zhou; Fredrick W Dahlquist; John Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

6.  Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP.

Authors:  Jian Xu; Pradeep Kurup; Yongfang Zhang; Susan M Goebel-Goody; Peter H Wu; Ammar H Hawasli; Matthew L Baum; James A Bibb; Paul J Lombroso
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

7.  Cocaine regulates MEF2 to control synaptic and behavioral plasticity.

Authors:  Suprabha Pulipparacharuvil; William Renthal; Carly F Hale; Makoto Taniguchi; Guanghua Xiao; Arvind Kumar; Scott J Russo; Devanjan Sikder; Colleen M Dewey; Maya M Davis; Paul Greengard; Angus C Nairn; Eric J Nestler; Christopher W Cowan
Journal:  Neuron       Date:  2008-08-28       Impact factor: 17.173

8.  The phospho-dependent dynamin-syndapin interaction triggers activity-dependent bulk endocytosis of synaptic vesicles.

Authors:  Emma L Clayton; Victor Anggono; Karen J Smillie; Ngoc Chau; Phillip J Robinson; Michael A Cousin
Journal:  J Neurosci       Date:  2009-06-17       Impact factor: 6.167

9.  Regulation of hippocampal and behavioral excitability by cyclin-dependent kinase 5.

Authors:  Ammar H Hawasli; Della Koovakkattu; Kanehiro Hayashi; Anne E Anderson; Craig M Powell; Christopher M Sinton; James A Bibb; Donald C Cooper
Journal:  PLoS One       Date:  2009-06-04       Impact factor: 3.240

10.  Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity.

Authors:  Dohoon Kim; Christopher L Frank; Matthew M Dobbin; Rachel K Tsunemoto; Weihong Tu; Peter L Peng; Ji-Song Guan; Byung-Hoon Lee; Lily Y Moy; Paola Giusti; Nisha Broodie; Ralph Mazitschek; Ivanna Delalle; Stephen J Haggarty; Rachael L Neve; Youming Lu; Li-Huei Tsai
Journal:  Neuron       Date:  2008-12-10       Impact factor: 17.173

View more
  24 in total

1.  Targeting CDK5 post-stroke provides long-term neuroprotection and rescues synaptic plasticity.

Authors:  Johanna A Gutiérrez-Vargas; Herman Moreno; Gloria P Cardona-Gómez
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  Cdk5 Contributes to Huntington's Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates.

Authors:  Elena Alvarez-Periel; Mar Puigdellívol; Verónica Brito; Florian Plattner; James A Bibb; Jordi Alberch; Silvia Ginés
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

3.  CDK5 knockdown prevents hippocampal degeneration and cognitive dysfunction produced by cerebral ischemia.

Authors:  Johana A Gutiérrez-Vargas; Alejandro Múnera; Gloria P Cardona-Gómez
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-24       Impact factor: 6.200

4.  Cyclin-dependent kinase 5 in the ventral tegmental area regulates depression-related behaviors.

Authors:  Peng Zhong; Xiaojie Liu; Zhen Zhang; Ying Hu; Sarah J Liu; Martha Lezama-Ruiz; Milan Joksimovic; Qing-song Liu
Journal:  J Neurosci       Date:  2014-04-30       Impact factor: 6.167

5.  Neuronal Nitric Oxide Synthase in Nucleus Accumbens Specifically Mediates Susceptibility to Social Defeat Stress through Cyclin-Dependent Kinase 5.

Authors:  Chun-Yu Yin; Shu-Ying Huang; Ling Gao; Yu-Hui Lin; Lei Chang; Hai-Yin Wu; Dong-Ya Zhu; Chun-Xia Luo
Journal:  J Neurosci       Date:  2021-01-26       Impact factor: 6.167

6.  Locomotor conditioning by amphetamine requires cyclin-dependent kinase 5 signaling in the nucleus accumbens.

Authors:  Bryan F Singer; Nichole M Neugebauer; Justin Forneris; Kelli R Rodvelt; Dongdong Li; Nancy Bubula; Paul Vezina
Journal:  Neuropharmacology       Date:  2014-06-02       Impact factor: 5.250

7.  Phosphorylation of cyclin-dependent kinase 5 (Cdk5) at Tyr-15 is inhibited by Cdk5 activators and does not contribute to the activation of Cdk5.

Authors:  Hiroyuki Kobayashi; Taro Saito; Ko Sato; Kotaro Furusawa; Tomohisa Hosokawa; Koji Tsutsumi; Akiko Asada; Shinji Kamada; Toshio Ohshima; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

8.  The Crucial Role of Cyclin-Dependent Kinase-5-Ataxia-Telangiectasia Mutated Axis in ICH-Induced Neuronal Injury of Rat Model.

Authors:  Jing Wu; Xin Zhang; Yi Yan; Zhaohua Tang; Xiaochuan Sun; Gang Huo; Zhengbu Liao
Journal:  Mol Neurobiol       Date:  2015-11-14       Impact factor: 5.590

Review 9.  Neuroprotective Mechanisms Mediated by CDK5 Inhibition.

Authors:  Gohar Mushtaq; Nigel H Greig; Firoz Anwar; Fahad A Al-Abbasi; Mazin A Zamzami; Hasan A Al-Talhi; Mohammad A Kamal
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 10.  DISC1 as a therapeutic target for mental illnesses.

Authors:  Takatoshi Hikida; Nao J Gamo; Akira Sawa
Journal:  Expert Opin Ther Targets       Date:  2012-11-06       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.